Non-Invasive Prenatal Testing Market Research Report 2023-2028: Industry Growth, Share, Size and Forecast

How Big is the Non-Invasive Prenatal Testing (NIPT) Market ? ;

According to the latest report by IMARC Group, titled “Non-Invasive Prenatal Testing (NIPT) Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028,” The global non-invasive prenatal testing market size reached US$ 3.4 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 8.5 Billion by 2028, exhibiting a growth rate (CAGR) of 17.2% during 2023-2028.

What is Non-Invasive Prenatal Testing (NIPT) ? :

Non-Invasive Prenatal Testing (NIPT) is a breakthrough in the field of prenatal diagnosis that enables the detection of genetic abnormalities in a developing fetus without posing a risk to the pregnancy. It operates on the principle of analyzing fragments of fetal DNA that circulate in the mother's bloodstream. With a simple maternal blood draw, NIPT can identify several genetic disorders, including Down syndrome (trisomy 21), Edwards syndrome (trisomy 18), and Patau syndrome (trisomy 13), among others.

The key advantage of NIPT over traditional invasive methods, such as amniocentesis or chorionic villus sampling, is the significantly reduced risk of miscarriage. Generally performed after the 10th week of pregnancy, NIPT has become an integral part of prenatal care, providing invaluable information about fetal health and enabling informed decision-making for prospective parents.

Request Free Sample Report (Exclusive Offer on this report): https://www.imarcgroup.com/non-invasive-prenatal-testing-market/requestsample

Top Companies In Non-Invasive Prenatal Testing Market:

• Agilent Technologies Inc.
• Berry Genetics Inc.
• BGI Genomics Co. Ltd.
• Eurofins LifeCodexx GmbH
• F. Hoffmann-La Roche AG
• GE Healthcare, Igenomix
• Illumina Inc.
• Laboratory Corporation
• Natera Inc.
• Perkinelmer Inc.
• Thermo Fisher Scientific Inc.
• Yourgene Health

Non-Invasive Prenatal Testing Market Trends and Growth Analysis:

The escalating awareness and acceptance of prenatal testing due to its high accuracy and safety profile is propelling market demand. Additionally, the rising average maternal age and the associated increased risk of chromosomal abnormalities are significant factors. The market is also expanding as a result of technological developments such as the creation of more accurate NIPTs and the improvement of genetic testing methods. Along with this, global health organizations' incorporation of NIPT into standard prenatal care guidelines also significantly amplifies its adoption.

Apart from this, the rise of personalized medicine and the potential of NIPT to offer safe insights into the fetus's genetic makeup is a major market trend. Furthermore, increased healthcare spending and infrastructure development, especially in emerging economies, are fueling the optimistic outlook of the global NIPT market.

Ask Analyst for Instant Discount and Download Full Report with TOC & List of Figure: https://www.imarcgroup.com/non-invasive-prenatal-testing-market

Key Market Segmentation:

Breakup by Product Type:

• Consumables
• Instrument

Breakup by Test Type:

• Materni 21
• Harmony
• Panaroma
• Verifi
• NIFTY
• Others

Breakup by Technology:

• NGS
• WGS
• Others

Breakup by Test Type:

• Ultrasound Detection
• Biochemical Screening Tests
• Cell-Free DNA in Maternal Plasma Tests
• Fetal Cells in Maternal Blood Tests
• Others

Breakup by Application:

• Trisomy
• Microdeletions Syndrome
• Others

Breakup by End-User:

• Hospitals
• Diagnostic Laboratories
• Others

Breakup by Region:

• North America (United States, Canada)
• Asia Pacific (Germany, France, United Kingdom, Italy, Spain, Others)
• Europe (China, Japan, India, Australia, Indonesia, Korea, Others)
• Latin America (Brazil, Mexico, Others)
• Middle East and Africa (United Arab Emirates, Saudi Arabia, Qatar, Iraq, Other)

About Us

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Contact us:

IMARC Group

134 N 4th St. Brooklyn, NY 11249, USA

Email: sales@imarcgroup.com

Tel No:(D) +91 120 433 0800

Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800